Shares of Inovio Pharmaceuticals Inc. INO jumped 12.11% to $2.13 Wednesday, on what proved to be an all-around mixed trading ...

This was the stock's fourth consecutive day of losses.

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus.

Between February 3, 2025, and February 7, 2025, Essity Aktiebolag (publ) repurchased a total of 270,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on aTyr Pharma (ATYR – Research Report), Crispr Therapeutics AG ...

After hours: 7:50:05 p.m. EST ...

After hours: 7:50:05 pm GMT-5 ...